Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsErkut Borazanci, Josep Tabernero, D.V. Hoff et al.|ESMO Open|2022Cited by 37